Breaking News

Nigerian lawmakers agree to 200 million dollars to compensate for the deficiency of US health aid discounts

Representative image (photo credit: AP)

Abuja: Nigerian lawmakers approved an additional $ 200 million for the health sector as part of the 2025 spending plan to compensate for the deficiency of American aid discounts.
Nigeria, the most country in Africa with more than 200 million people, was among the ten best aid recipients from the United States Agency for International Development in 2023. The US Agency for International Development was frozen for a period of 90 days by the Trump administration.
The Senator Senator Senate Specializations, the Senate Senate During the Parliament’s budget session on Thursday, said that the country may suffer from “harmful effects” from US foreign aid discounts, especially those that affect the efforts to control diseases.
The $ 200 million spending plan, which is part of the $ 36.6 billion in the federal budget, “fill the gap established by the suspension of the US government’s intervention to the health sector,” according to the draft law approved on Thursday. Many money aims to provide vaccines and treatment for epidemic diseases.
The United States has invested more than $ 600 million in Nigeria’s health aid in 2023 alone, according to the American embassy in Nigeria, most of which are to support efforts to prevent malaria, end HIV and provide vaccines.
The freezing of financing from the United States can also affect the country on other fronts, including humanitarian assistance in the northeast where Islamic extremists have launched a rebellion against the government since 2009, which led the Cameroon.
For example, the United Nations International Development Agency has held a partnership with the United Nations Immigration Agency in Nigeria in the fast response fund project that deals with emergency situations such as shelter, sanitation and protection in the conflict capacity.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker